Skip to main content
Year archive

AFT Pharmaceuticals Limited — 2016 filings

All 10 regulatory filings released by AFT Pharmaceuticals Limited (AFT) in 2016, sourced directly from the official regulator.

10 Filings
2016 Period
2016 filings (10)
Filing Released Lang
AFT – Maxiclear now licensed in additional 16 Countries
Capital/Financing Update
2016-12-27 English
Waiver from NZX Main Board Listing Rule 5.2.3
Regulatory Filings
2016-12-21 English
TGA decision will boost Maxigesic sales in Australia
Regulatory Filings
2016-12-19 English
AFT – PHARMAC issues RFP for Metoprolol heart medication
Capital/Financing Update
2016-12-15 English
AFT hits target to register NasoSURF with the FDA in the US
Regulatory Filings
2016-11-30 English
AFT Presentation FY2017 1H Year Update – amended
Investor Presentation
2016-11-24 English
AFT Half Year Announcement
Interim / Quarterly Report
2016-11-23 English
AFT Half Year Announcement App I
Interim / Quarterly Report
2016-11-23 English
AFT Pharmaceuticals Presentation FY2017 1H Year Update
Investor Presentation
2016-11-23 English
AFT Interim Report H1 FY17
Interim / Quarterly Report
2016-11-23 English